Erectile dysfunction from prostate cancer hormone therapy treatable

Men with advanced prostate cancer may be given androgen deprivation therapy to stop their production of testosterone, which may drive tumor growth.

 A new study shows that a substantial minority of men receiving so-called androgen deprivation therapy, or ADT, for prostate cancer experience erectile dysfunction (ED). However, many respond well to ED therapy, doctors from Memphis have found.